Ingvild Gudim

Title: Ingvild Gudim: Innovator in Medical Diagnostics

Introduction

Ingvild Gudim is a notable inventor based in Moss, Norway. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patent related to the quantification of NT-proBNP.

Latest Patents

Ingvild Gudim holds a patent for a highly sensitive particle-enhanced assay for the quantification of NT-proBNP. This assay allows for the determination of NT-proBNP in biological samples using at least one antibody that recognizes an epitope of NT-proBNP in both glycosylated and non-glycosylated forms. The preferred antibody is an isolated polyclonal antibody or a mixture of monoclonal antibodies coated onto a particle. The coating ratio is ideally between 6-60%, forming a layer or multiple layers of antibodies on the particle. This assay can be realized in the form of a nephelometric or turbidimetric assay and is applicable to a wide range of automated clinical analyzers.

Career Highlights

Ingvild Gudim is associated with Gentian AS, where he continues to work on advancements in medical diagnostics. His expertise in assay development has positioned him as a key player in the field.

Collaborations

Ingvild collaborates with talented individuals such as Torsten Knüttel and Berit Løseth, who contribute to the innovative environment at Gentian AS.

Conclusion

Ingvild Gudim's work in developing a sensitive assay for NT-proBNP exemplifies his commitment to advancing medical diagnostics. His contributions are significant in improving the accuracy and efficiency of clinical testing.